Award funds oropharyngeal cancer outcomes study
June 23, 2015 -- The Patient-Centered Outcomes Research Institute's Pipeline to Proposal program has given a clinical research award to an otolaryngologist with Henry Ford Hospital in Detroit to study treatment options and post-treatment rehabilitation for oropharyngeal cancer patients.
OncoSec enrolls 1st patient in immunotherapy clinical trial
June 18, 2015 -- OncoSec Medical has enrolled the first patient in a phase II clinical trial that uses ImmunoPulse IL-12, an immunotherapy platform, to treat patients with squamous cell carcinoma of the head and neck.
NCI grants $10M for HNC research
June 17, 2015 -- The National Cancer Institute (NCI) has awarded the Roswell Park Cancer Institute of Buffalo, NY, a $10 million federal grant to continue its research program on photodynamic therapy, specifically in head and neck cancers.
Study: Pembrolizumab shows promise as HNC treatment
June 16, 2015 -- A new immunotherapy drug was found to be almost twice as effective as the preferred treatment for decreasing the size of the tumors of patients with recurrent or metastatic head and neck cancer (HNC), according to a study presented at the recent meeting of the American Society for Clinical Oncology.
Study: Half of oral cancer deaths due to cigarettes
June 15, 2015 -- Almost half of the deaths caused by cancers of the oral cavity and pharynx in U.S. adults age 35 and older in 2011 were attributable to cigarette smoking, according to a multi-institution research letter published June 15 in JAMA Internal Medicine.
SNMMI: PET/CT predicts survival in head and neck cancer
June 11, 2015 -- BALTIMORE - FDG-PET and FDG-PET/CT do a good job in predicting the chances of recurrence and survival for patients with head and neck cancer within two years of completing chemotherapy treatment, according to a study presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
Study finds chemo costly for oral cancer in elderly
June 4, 2015 -- Medicare costs for elderly patients with oral and pharyngeal cancers are significantly impacted by treatment selection, according to a new study. Chemotherapy patients cost the program $32,000 more on average over five years than those who picked alternative treatments.
Erectile dysfunction drug shows promise for HNSCC
May 27, 2015 -- The little yellow pills that have boosted men's sex lives for the past decade may someday fight head and neck cancers and other diseases, according to Florida researchers. The erectile dysfunction drug tadalafil, commonly known as Cialis, can modulate the body's immune system, resulting in a new therapeutic strategy for head and neck squamous cell carcinoma (HNSCC), a new trial has shown.
Study: Oral cancer campaign increases awareness among black men
May 27, 2015 -- A campaign to increase awareness of oral cancer among black men resulted in more screenings for the disease in Florida's poorest counties, according to a new study in the American Journal of Public Health.
Study: Follow-up, smoking, travel distance affect HNC survival
May 14, 2015 -- Patients with head and neck cancer (HNC) have better survival rates when they attend follow-up visits, quit smoking, have good incomes, and live close to medical centers, according to a new study.
Featured Free CE
Oral Cancer Awareness
For Oral Cancer Awareness DrBicuspid is providing the following two courses for Free to our Members. Oral Cancer: The Role of the Dental Professional Part 1 and Part 2
Special Feature
Aspirin can help battle head/neck cancer
Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer. Read more.
VENDOR CONNECT
Dentifrices and Consumer Products
Dry Mouth Products
Tools and Instruments
Oral Cancer Detection
Conferences